OUR PRODUCT TECHNOLOGY
Verde Technologies is committed to developing research-based, scientifically proven solutions to reduce drug abuse and misuse. Originally introduced as Medsaway, the Deterra® Drug Deactivation System is powered by the same patented MAT12® Molecular Adsorption Technology, which deactivates prescription drugs using proprietary activated carbon. The technology is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive and ineffective for misuse and safe for the environment.
MAT12® Molecular Adsorption Technology
Patented, proprietary activated carbon bonds to pharmaceutical compounds, rendering drugs ineffective and safe for disposal.
Deterra® System Technology
A key component of our patented technology is a proprietary activated carbon. Owing to its affinity for organic compounds, activated carbon is considered to be a universal adsorbent. Pharmaceutical molecules and toxins will bind to activated carbon through intermolecular forces, and pharmaceuticals that are bound to the activated carbon will no longer be mobile nor physiologically active (e.g. deactivated). Activated carbon has been frequently administered to patients for the treatment of acute overdose and poisoning in emergency situations. It has been found to effectively bind a wide variety of drugs and poisons with a few notable exceptions (e.g. iron, lithium, potassium, and ethanol).
Deterra’s at-source chemical neutralization system works safely to deactivate the medications by a proprietary activated carbon system. Activated carbon is used extensively in municipal water purification, and is recognized as a universal adsorbent for chemicals in solution. It is also used in the emergency treatments of drug overdosage.